Dataset Information


Defining the clinical course of multiple sclerosis: the 2013 revisions.

ABSTRACT: Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important for communication, prognostication, design and recruitment of clinical trials, and treatment decision-making. Standardized descriptions published in 1996 based on a survey of international MS experts provided purely clinical phenotypes based on data and consensus at that time, but imaging and biological correlates were lacking. Increased understanding of MS and its pathology, coupled with general concern that the original descriptors may not adequately reflect more recently identified clinical aspects of the disease, prompted a re-examination of MS disease phenotypes by the International Advisory Committee on Clinical Trials of MS. While imaging and biological markers that might provide objective criteria for separating clinical phenotypes are lacking, we propose refined descriptors that include consideration of disease activity (based on clinical relapse rate and imaging findings) and disease progression. Strategies for future research to better define phenotypes are also outlined.


PROVIDER: S-EPMC4117366 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6985036 | BioStudies
2019-01-01 | S-EPMC6453990 | BioStudies
2016-01-01 | S-EPMC4831039 | BioStudies
2015-01-01 | S-EPMC4444291 | BioStudies
2015-01-01 | S-EPMC4602048 | BioStudies
1000-01-01 | S-EPMC3127768 | BioStudies
2018-01-01 | S-EPMC5821573 | BioStudies
2020-01-01 | S-EPMC7643842 | BioStudies
2014-01-01 | S-EPMC4023333 | BioStudies
2012-01-01 | S-EPMC3327801 | BioStudies